Press release
Compounding Pharmacies Market is expected to reach US$ 21.3 Bn by the end of 2031 to register a CAGR of 8.3%
Compounding Pharmacies Market 2022
The global market for compounding pharmacies is worth US$ 9.6 Bn in 2021. The market is expected to reach US$ 21.3 Bn by the end of 2031, with sales revenue expected to register a CAGR of 8.3% over the same period. Traditional compounding pharmacies operating without FDA supervision and increasing compounding independent store formats are major key trends shaping market expansion.
Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/5270
Increasing number of patients visiting physicians to seek medical attention for chronic conditions and high need for prescription medications are resulting in an expanding global market for compounding pharmacies. Compounded pharmacists provide customized medications to patients who cannot acquire outcomes from taking commercially accessible pharmaceuticals. Demand for customized hormone replacement therapies have increased in the recent past as people have become more conscious about important health functions such as breast and bone health, erectile longevity, osteoporosis, mood swings, hot flashes, acute levels of depression, etc.
Accordingly, dosage requirements for specific customized solutions driven demand for hormones such as progesterone after hysterectomy, testosterone replacement, infertility curing hormones, etc. These therapies are expensive and in high demand, owing to rapid growth of lifestyle-related diseases in the young population due to lifestyle changes and increasing stress levels.
Key players are focusing on strengthening their position by collaborating with local manufacturers and acquisitions to enhance their sales. Moreover, companies are targeting North America, Asia Pacific, and Europe through the adoption of research & development and partnerships in the market.
In November 2020, B. Braun Melsungen AG and Grifols formed a strategic partnership to enhance compounding pharmacy production output and services for hospitals. Grifols is a leading producer of plasma-derived medicines and has compounding centres across the U.S.
In February 2016, PharMEDium Services, LLC announced a sole source agreement with Premier, Inc. to provide a wide range of services used for pain management, operating room anaesthesia, intensive care, nerve block, and labour and delivery.
Such developments not only strengthen a company's existing portfolio but also help increase its presence at regional as well as global levels.
Company Profiles:
Fagron
Fresenius Kabi AG
PharMEDium Services, LLC
Institutional Pharmacy Solutions
Cantrell Drug Company
Lorraine's Pharmacy
B.Braun Melsungen AG
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/5270
Key Takeaways from Market Study
By product, oral medication is set to hold a high share of 43.5% in 2021, expanding at 9.6% CAGR during the forecast period.
By application, medication for adults will hold a high share of 53.3% in 2021, expanding at 9.5% CAGR during the forecast period.
In terms of therapeutic area, hormone replacement therapy accounts for 63.5% market share in 2021.
By region, North America held the largest share of 66.3% in 2021, due to emergence of new compounding pharmacies in North America to meet growing need for specialized care and hard drugs.
"Rising medicinal droughts in required medication levels across the world, increasing cost of branded prescription equivalents, and inadequate accessibility to drugs are expected to drive demand for compounding pharmacies," says an analyst of Persistence Market Research.
Who is Winning?
Some of the leading manufacturers of compounding pharmacies are focusing on product approvals, acquisitions, mergers, collaborations, and partnerships for global expansion objectives, thereby enhancing their market presence.
On May 27, 2020, the US FDA accepted for review Fresenius Kabi's first biosimilar regulatory submission for MSB11455, a biosimilar candidate of pegfilgrastim.
In April 2018, Fagron acquired Humco, a developer, manufacturer, and supplier of patented delivery vehicles and branded pharmaceutical products in the U.S.
In September 2015, Lorraine's Pharmacy received funds worth US$ 53.9 Mn from the U.S. government in order to get FDA approval for its product ReCell, an autologous cell harvesting device.
In mid-2015, Fagron merged with AnazaoHealth Corporation, which specializes in nuclear, pain, and intrathecal customized medication.
Key market players covered in the research by Persistence Market Research include Fagron, Fresenius Kabi AG, PharMEDium Services, LLC, Institutional Pharmacy Solutions, Cantrell Drug Company, Lorraine's Pharmacy, and B. Braun Melsungen AG Company.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the compounding pharmacies in its latest study, presenting historical demand assessment of 2016 - 2020 and projections for 2021 - 2031.
The study provides compelling insights into compounding pharmacies market. The market is segmented into product (oral medication (capsules, tablets, mixtures, lollipops, lozenges), topical medication (gels, ointments, cream, lotions, mouthwashes, and suppositories)), application (medication for adults, medication for veterinary, medication for children, and medication for geriatric), and therapeutic area (pain management and hormone replacement therapy), across five major regions of the world.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/5270
Key Questions Answered in This Report.
What will the Market growth rate in Future?
What are the key factors driving the global Market?
Who are the key manufacturers in Market space?
What are the opportunities and threats faced by the vendors in the global industry?
What are sales, revenue, and price analysis by regions of industry?
Related Reports:
Attention Deficit Hyperactivity Disorder Therapeutics Market - https://www.persistencemarketresearch.com/market-research/attention-deficit-hyperactivity-disorder-therapeutics-market.asp
Cancer Supportive Care Products Market - https://www.persistencemarketresearch.com/market-research/cancer-supportive-care-products-market.asp
Contact Us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Japan Office: 1-2-1 Kinshi Arca Central Building
14/F Tokyo, 130-0013, Japan
Call 1-888-863-3700
About Us:
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Compounding Pharmacies Market is expected to reach US$ 21.3 Bn by the end of 2031 to register a CAGR of 8.3% here
News-ID: 2730867 • Views: …
More Releases from Persistence Market Research
Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market
The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to…
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market
The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in…
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market
The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According…
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market
The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained…
More Releases for Compounding
Compounding Pharmacies Business Development Strategies for Expanding Your Market …
The global compounding pharmacies market size was US$ 8.1 billion in 2021. The global compounding pharmacies market size is estimated to reach US$ 13.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period from 2022 to 2030.
Request To Download Sample of This Strategic Report :-https://reportocean.com/industry-verticals/sample-request?report_id=bwcc17220
A compounding pharmacy is a distinctive kind of pharmacy. They can create customized medicines for the individual who…
NBR Compounding Market Report Status And Outlook 2022-2027-Hexpol Compounding, P …
The NBR Compounding Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. We analyzed the impact of…
Global Compounding Pharmacies Market, Global Compounding Pharmacies Industry, Co …
The Compounding Pharmacies market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Compounding Pharmacies Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Compounding Pharmacies market. The report focuses on well-known providers in the global…
U.S. Compounding Pharmacies Market Global Key Players - Premier Pharmacy Labs, R …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is…
U.S. Compounding Pharmacies Market ; Eminent Players - Pencol Compounding Pharma …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is…
U.S. Compounding Pharmacies Market Key Players – McKesson Corporation, Nephron …
U.S. Compounding Pharmacies Market size is set to exceed USD 7 billion by 2025; according to a new research report by Global Market Insights, Inc.
Growing prevalence of chronic diseases in the U.S. such as cancer, diabetes, cardiovascular disease, respiratory diseases and obesity will drive the U.S. compounding pharmacies market growth over the forecast period. Increasing drug shortage in the country due to production delays and unavailability of previously manufactured…
